{"id":"https://openalex.org/W4385295752","doi":"https://doi.org/10.2217/fon-2023-0117","title":"Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting","display_name":"Durvalumab real-world treatment patterns and outcomes in patients with stage III non-small-cell lung cancer treated in a US community setting","alternate_titles":[],"publication_year":2023,"publication_date":"2023-07-27","ids":{"openalex":"https://openalex.org/W4385295752","doi":"https://doi.org/10.2217/fon-2023-0117","pmid":"https://pubmed.ncbi.nlm.nih.gov/37497677"},"language":"en","primary_location":{"id":"doi:10.2217/fon-2023-0117","doi":"https://doi.org/10.2217/fon-2023-0117","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2023-0117","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4385295752"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.2217/fon-2023-0117","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053359739","display_name":"David Michael Waterhouse","orcid":"https://orcid.org/0000-0001-5589-9939","observed_orcids":["https://orcid.org/0000-0001-5589-9939"]},"institutions":[{"id":"https://openalex.org/I4210153992","display_name":"Oncology Hematology Care","ror":"https://ror.org/04gqr8882","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210153992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Waterhouse","raw_affiliation_strings":["Oncology Hematology Care, Inc. 5053 Wooster Rd, Cincinnati, OH 45226"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Hematology Care, Inc. 5053 Wooster Rd, Cincinnati, OH 45226","institution_ids":["https://openalex.org/I4210153992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101885412","display_name":"Candice Yong","orcid":"https://orcid.org/0000-0002-9264-0720","observed_orcids":["https://orcid.org/0000-0002-9264-0720"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Candice Yong","raw_affiliation_strings":["AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032195937","display_name":"Andrew J. Frankart","orcid":"https://orcid.org/0000-0002-1220-6511","observed_orcids":["https://orcid.org/0000-0002-1220-6511"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Frankart","raw_affiliation_strings":["Department of Radiation Oncology,University of Cincinnati,\r2600 Clifton Ave.\rCincinnati,\rOH 45221"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology,University of Cincinnati,\r2600 Clifton Ave.\rCincinnati,\rOH 45221","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067661627","display_name":"Lance Brannman","orcid":"https://orcid.org/0000-0003-1189-8074","observed_orcids":["https://orcid.org/0000-0003-1189-8074"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lance Brannman","raw_affiliation_strings":["AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045949789","display_name":"Tiernan J. Mulrooney","orcid":"https://orcid.org/0000-0002-0218-2771","observed_orcids":["https://orcid.org/0000-0002-0218-2771"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tiernan Mulrooney","raw_affiliation_strings":["AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075481530","display_name":"Nicholas J. Robert","orcid":"https://orcid.org/0000-0002-8491-5392","observed_orcids":["https://orcid.org/0000-0002-8491-5392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas Robert","raw_affiliation_strings":["Ontada 33 Arch St,\rBoston,\rMA 02109"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada 33 Arch St,\rBoston,\rMA 02109","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024131713","display_name":"Kathleen M. Aguilar","orcid":"https://orcid.org/0000-0002-2467-8663","observed_orcids":["https://orcid.org/0000-0002-2467-8663"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen M Aguilar","raw_affiliation_strings":["Ontada 33 Arch St,\rBoston,\rMA 02109"],"raw_orcid":"https://orcid.org/0000-0002-2467-8663","affiliations":[{"raw_affiliation_string":"Ontada 33 Arch St,\rBoston,\rMA 02109","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066126098","display_name":"Juliet Ndukum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliet Ndukum","raw_affiliation_strings":["Ontada 33 Arch St,\rBoston,\rMA 02109"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada 33 Arch St,\rBoston,\rMA 02109","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087878110","display_name":"Ion Cotarla","orcid":"https://orcid.org/0000-0002-8986-3616","observed_orcids":["https://orcid.org/0000-0002-8986-3616"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ion Cotarla","raw_affiliation_strings":["AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca,\r1 MedImmune Way,\rGaithersburg,\rMaryland 20878","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"AstraZeneca, 1 MedImmune Way Gaithersburg, Maryland 20878 University of Cincinnati","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9471,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.86251879,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"19","issue":"28","first_page":"1905","last_page":"1916"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.7958999872207642,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.1193000003695488,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.05009999871253967,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":1.0},{"id":"https://openalex.org/keywords/stage-iii-non-small-cell-lung-cancer","display_name":"stage III NSCLC","score":0.9760000109672546},{"id":"https://openalex.org/keywords/consolidation-immunotherapy","display_name":"consolidation immunotherapy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.9879999756813049},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7080000042915344},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8640000224113464},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.847000002861023},{"id":"https://openalex.org/keywords/community-oncology","display_name":"community oncology","score":0.7829999923706055},{"id":"https://openalex.org/keywords/inoperable-lung-cancer","display_name":"inoperable lung cancer","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.9904095530509949},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9108037948608398},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6373729705810547},{"id":"https://openalex.org/C2778424827","wikidata":"https://www.wikidata.org/wiki/Q5090613","display_name":"Chemoradiotherapy","level":3,"score":0.6123343110084534},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5076688528060913},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4951542913913727},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44137388467788696},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4239165484905243},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.11548572778701782},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059248","descriptor_name":"Chemoradiotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2217/fon-2023-0117","doi":"https://doi.org/10.2217/fon-2023-0117","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2023-0117","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:37497677","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37497677","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.2217/fon-2023-0117","doi":"https://doi.org/10.2217/fon-2023-0117","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2023-0117","pdf_url":null,"source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1999130958","https://openalex.org/W2586030734","https://openalex.org/W2586810147","https://openalex.org/W2613823791","https://openalex.org/W2753065806","https://openalex.org/W2893824814","https://openalex.org/W2980537150","https://openalex.org/W2995072671","https://openalex.org/W3016080515","https://openalex.org/W3022263550","https://openalex.org/W3028746215","https://openalex.org/W3044858467","https://openalex.org/W3107733830","https://openalex.org/W3108819942","https://openalex.org/W3169762113","https://openalex.org/W3203228606","https://openalex.org/W3203773970","https://openalex.org/W3214742056","https://openalex.org/W4210477674","https://openalex.org/W4210772672","https://openalex.org/W4283515842","https://openalex.org/W4307584521","https://openalex.org/W4318070818"],"related_works":["https://openalex.org/W7127602539","https://openalex.org/W4409326982","https://openalex.org/W4379280635","https://openalex.org/W4412900027","https://openalex.org/W7169718676","https://openalex.org/W4409598359","https://openalex.org/W3199349574","https://openalex.org/W4210772672","https://openalex.org/W4394997659","https://openalex.org/W4391484865"],"abstract_inverted_index":{"Background:":[0],"For":[1],"eligible":[2],"patients":[3,29,61],"with":[4,46,90,102,111],"unresectable":[5],"stage":[6],"III":[7,118],"non-small-cell":[8],"lung":[9],"cancer,":[10],"durvalumab":[11,103],"consolidation":[12],"therapy":[13],"following":[14],"chemoradiotherapy":[15,105],"is":[16],"the":[17,68,112,115],"standard":[18],"of":[19,27,52,71],"care.":[20],"Methods:":[21],"This":[22,96],"was":[23,73],"a":[24,107],"retrospective":[25],"study":[26,97],"durvalumab-treated":[28],"diagnosed":[30],"between":[31],"1":[32],"August":[33],"2017":[34],"and":[35,54,81,87],"29":[36],"February":[37],"2020.":[38],"Electronic":[39],"health":[40],"record":[41],"data":[42],"were":[43,85],"assessed":[44],"descriptively,":[45],"Kaplan\u2013Meier":[47],"methods":[48],"used":[49],"for":[50],"duration":[51,70],"treatment":[53,72],"overall":[55],"survival":[56],"(OS).":[57],"Results:":[58],"Among":[59],"528":[60],"(median":[62],"age":[63],"70":[64],"years,":[65],"51.5%":[66],"male),":[67],"median":[69,91],"7.1":[74],"months":[75],"(95%":[76],"CI:":[77],"6.0\u20139.0).":[78],"Estimated":[79],"1-":[80],"2-year":[82],"OS":[83,92,100],"rates":[84],"83.5":[86],"64.0%,":[88],"respectively,":[89],"not":[93],"reached.":[94],"Conclusion:":[95],"confirmed":[98],"an":[99],"benefit":[101],"after":[104],"in":[106],"real-world":[108],"setting,":[109],"consistent":[110],"results":[113],"from":[114],"PACIFIC":[116],"phase":[117],"clinical":[119],"trial.":[120]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4385295752","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2023-07-28T00:00:00"}
